iCM012 solution 2 mg/mL for reperfusion injury

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Sep 2024: Trial registered, NCT06582485

The trials

NCT06582485: A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys

State
Not started
Phase
Phase 2 and Phase 3
People
200 planned
Started
Sep 2025
Primary completion
Dec 2026
Arms
Active treatment iCM012 solution 2 mg/mL
Results
None posted
  1. 3 Sep 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.